Violation Tracker Individual Record

Company: 
Eli Lilly and Company
Current Parent Company: 
Eli Lilly
Penalty: 
$1,415,000,000
Primary Offense: 
off-label or unapproved promotion of medical products
Violation Description: 

Eli Lilly and Company agreed to plead guilty and pay $1.415 billion for promoting its drug Zyprexa for uses not approved by the Food and Drug Administration. This resolution included a criminal fine of $515 million, the forfeiture of $100 million in assets, and up to $800 million in a civil settlement with the federal government and the states.

Year: 
2009
Date: 
January 15, 2009
Agency: 
Justice Department Civil Division
Civil or Criminal Case: 
civil and criminal
HQ Country of Parent: 
USA
HQ State of Parent: 
Indiana
Ownership Structure of Parent: 
publicly traded
Major Industry of Parent: 
pharmaceuticals
Specific Industry of Parent: 
pharmaceuticals
Source Notes: 
If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Parent company note: 
Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.